1. Home
  2. EVTL vs ENTX Comparison

EVTL vs ENTX Comparison

Compare EVTL & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$5.56

Market Cap

542.9M

Sector

Industrials

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.77

Market Cap

142.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
ENTX
Founded
2016
2010
Country
United Kingdom
Israel
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
542.9M
142.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
EVTL
ENTX
Price
$5.56
$1.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$13.20
$10.00
AVG Volume (30 Days)
2.5M
78.2K
Earning Date
08-05-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$124,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.25
52 Week Low
$2.76
$1.50
52 Week High
$15.99
$3.22

Technical Indicators

Market Signals
Indicator
EVTL
ENTX
Relative Strength Index (RSI) 52.77 27.62
Support Level $5.03 $2.07
Resistance Level $5.80 $2.22
Average True Range (ATR) 0.66 0.16
MACD -0.08 -0.03
Stochastic Oscillator 35.20 0.00

Price Performance

Historical Comparison
EVTL
ENTX

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: